Work

Accelerated rTMS: Complexities and clinical translation

Year: 2026

Type: article

Abstract: Major depressive disorder (MDD) is a severe and commonly occurring psychiatric illness with a substantial proportion of patients failing to respond adequately to standard treatments, often referred to as treatment-resistant depression (TRD). Repetitive transcranial magnetic stimulation (rTMS) has been developed as a safe and clinically effective intervention for TRD and is now increasingly accessible in routine clinical settings [1]. Although rTMS produces meaningful antidepressant effects for many patients, the standard delivery schedule is time intensive and clinical response typically occurs gradually.

Source: Brain stimulation

DOI: 10.1016/j.brs.2026.103057

Authors: Paul B. Fitzgerald, Jim Lagopoulos, Xianwei Che

Institutions: Australian National University, Hangzhou Normal University, Affiliated Hospital of Hangzhou Normal University

Language: English

Topic: Transcranial Magnetic Stimulation Studies

Subfield: Neurology

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,430